1. Home
  2. WWR vs CPIX Comparison

WWR vs CPIX Comparison

Compare WWR & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WWR
  • CPIX
  • Stock Information
  • Founded
  • WWR 1977
  • CPIX 1999
  • Country
  • WWR United States
  • CPIX United States
  • Employees
  • WWR N/A
  • CPIX N/A
  • Industry
  • WWR Metal Mining
  • CPIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • WWR Basic Materials
  • CPIX Health Care
  • Exchange
  • WWR Nasdaq
  • CPIX Nasdaq
  • Market Cap
  • WWR N/A
  • CPIX 40.1M
  • IPO Year
  • WWR N/A
  • CPIX 2009
  • Fundamental
  • Price
  • WWR $0.59
  • CPIX $3.04
  • Analyst Decision
  • WWR Strong Buy
  • CPIX
  • Analyst Count
  • WWR 1
  • CPIX 0
  • Target Price
  • WWR $2.00
  • CPIX N/A
  • AVG Volume (30 Days)
  • WWR 607.4K
  • CPIX 113.7K
  • Earning Date
  • WWR 08-13-2025
  • CPIX 08-05-2025
  • Dividend Yield
  • WWR N/A
  • CPIX N/A
  • EPS Growth
  • WWR N/A
  • CPIX N/A
  • EPS
  • WWR N/A
  • CPIX N/A
  • Revenue
  • WWR N/A
  • CPIX $41,083,299.00
  • Revenue This Year
  • WWR N/A
  • CPIX N/A
  • Revenue Next Year
  • WWR N/A
  • CPIX N/A
  • P/E Ratio
  • WWR N/A
  • CPIX N/A
  • Revenue Growth
  • WWR N/A
  • CPIX 5.82
  • 52 Week Low
  • WWR $0.45
  • CPIX $1.04
  • 52 Week High
  • WWR $1.32
  • CPIX $7.25
  • Technical
  • Relative Strength Index (RSI)
  • WWR 58.04
  • CPIX 41.13
  • Support Level
  • WWR $0.59
  • CPIX $3.00
  • Resistance Level
  • WWR $0.63
  • CPIX $3.76
  • Average True Range (ATR)
  • WWR 0.03
  • CPIX 0.53
  • MACD
  • WWR -0.00
  • CPIX -0.02
  • Stochastic Oscillator
  • WWR 50.00
  • CPIX 27.95

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: